Ron Bose

14PUBLICATIONS
173CO-AUTHORS
Tumour immunologyMolecular targetsPredictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 21, 2026
Interleukin-34-Induced Arg1+ Macrophages Play a Key Role in Breast Cancer Brain Metastasis.

|Apr 06, 2026
Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial.

Komal Jhaveri, Lisa D Eli, Sara A Hurvitz

|Jan 27, 2026
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.

Tim Kong, Alex Mabry, Maureen Highkin

|Jul 17, 2025
HER2; p53 Co-mutated Cancers Show Increased Histone Acetylation and are Sensitive to Neratinib plus Trastuzumab Deruxtecan.

Xiaoqing Cheng, Jacob Hsia, Jesus Iraheta

|Jul 16, 2025
Cerebellum metastasis model of HER2-positive breast cancer unveils key role of IL34-induced Arg1+ macrophages.

Xiaoqing Cheng, Khooshbu Kantibhai Patel, Brandon Zhou

|Jun 13, 2025
ctDNA Analysis in ERBB2-Amplified Colorectal Cancer: Biomarker Analysis of the MyPathway Trial.

Funda Meric-Bernstam, Kanwal Pratap Singh Raghav, Christopher J Sweeney

Pageof 3

Frequent Collaborators

4 joint publications

Cynthia X Ma

4 joint publications

Foluso O Ademuyiwa

3 joint publications

Ian S Hagemann

3 joint publications

Eric P Winer